Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Receives Conditional Approval for Thyroid Test in NY State

NEW YORK (GenomeWeb) – Rosetta Genomics announced today that it has received conditional approval from the New York State Department of Health (NYSDOH) for the RosettaGX Reveal thyroid cancer diagnostic assay.

The test is designed to analyze the expression of microRNA biomarkers in indeterminate thyroid fine needle aspirate smears to differentiate benign thyroid nodules from malignant ones.

Although the test is CLIA certified, Rosetta said that it requires an additional license from the NYSDOH to offer the test in the state. With the conditional approval, Rosetta may sell the test in New York pending final approval from the health department. 

In August, Rosetta received NYSDOH clearance for its fluorescence in situ hybridization-based ROS1 lung cancer biomarker assay.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.